Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 153 participants.
Also called NCT01234649
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 153 participants
- Sponsor
- Registry
-
NCT01234649
-
- Other papers using this trial's data
- Postpartum treatment with liraglutide in combination with metformin versus metformin monotherapy to improve metabolic status and reduce body weight in overweight/obese women with recent gestational diabetes: A double-blind, randomized, placebo-controlled study
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01234649. Randomized; triple masking; primary purpose prevention. Start 2011-08-11 (actual); primary completion 2019-04-24 (actual). Results posted on 2019-07-26.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
- Condition
- Gestational Diabetes Mellitus
- Condition
- Type 2 Diabetes Mellitus
- Condition
- Metabolic Syndrome
- Condition
- Impaired Glucose Tolerance
- Condition
- Disorder of Glucose Regulation
- Intervention (Drug)
- Metformin XR plus placebo
- Intervention (Drug)
- Metformin XR plus liraglutide
- Lead sponsor
- Woman's
- Collaborator
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct01234649- Content hash
447687caaaae4a7ac967bd8f743c18ae668fef34893836838995f007db87c9ec